A Novel Antiviral Therapeutic Platform: Anchoring IFN-β to the Surface of Infectious Virions Equips Interferon-Evasive Virions with Potent Antiviral Activity
The COVID-19 pandemic highlighted the need for new therapeutic strategies to counter emerging pathogenic viruses. Herein, we introduce a novel fusion protein platform that enables antiviral targeting of distinct viral species based on host receptor specificity. Proof-of-concept studies focused on th...
Saved in:
| Main Authors: | Hoda H. Jabbour, Alexander G. Bastian, Kayla B. DeOca, Mark D. Mannie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/5/697 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral Effects of Avian Interferon-Stimulated Genes
by: Xingchen He, et al.
Published: (2024-10-01) -
REGγ regulates antiviral response by activating TBK1-IFNβ signaling through degradation of PPP2CB
by: Yi Li, et al.
Published: (2025-07-01) -
SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses
by: Weiyi Tang, et al.
Published: (2025-03-01) -
Evaluation of the pharmacokinetics of an experimental combined form of IFNα and IFNγ for intranasal use
by: E. V. Kravchenko, et al.
Published: (2024-09-01) -
Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro
by: Igor Andrade Santos, et al.
Published: (2025-05-01)